Access Statistics for Iain M. Cockburn
Author contact details at EconPapers.
| Working Paper |
File Downloads |
Abstract Views |
| Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
| A Mixed Poisson Regression Model for Analysis of Patent Data |
0 |
0 |
0 |
290 |
15 |
37 |
113 |
1,408 |
| Are All Patent Examiners Equal? The Impact of Examiner Characteristics |
1 |
5 |
31 |
304 |
10 |
28 |
149 |
1,597 |
| Balancing Incentives: The Tension Between Basic and Applied Research |
1 |
4 |
25 |
363 |
5 |
23 |
94 |
1,542 |
| Characteristics of Demand for Pharmaceutical Products: an Examination of four Cephalosporins |
0 |
0 |
0 |
0 |
20 |
49 |
210 |
1,908 |
| Do Patents Matter?: Empirical Evidence after GATT |
2 |
4 |
26 |
257 |
4 |
10 |
51 |
661 |
| Entry, Exit and Patenting in the Software Industry |
1 |
2 |
18 |
134 |
7 |
20 |
82 |
333 |
| Faster, Smaller, Cheaper: An Hedonic Price Analysis of PDAs |
2 |
4 |
11 |
86 |
4 |
10 |
36 |
283 |
| Generics and New Goods in Pharmaceutical Price Indexes |
2 |
8 |
39 |
176 |
13 |
43 |
184 |
734 |
| Gone But Not Forgotten: Labor Flows, Knowledge Spillovers, and Enduring Social Capital |
2 |
12 |
33 |
196 |
7 |
32 |
109 |
575 |
| Hedonic Analysis of Arthritis Drugs |
3 |
4 |
7 |
144 |
5 |
8 |
18 |
906 |
| Industry Effects and Appropriability Measures in the Stock Markets Valuation of R&D and Patents |
2 |
8 |
38 |
261 |
8 |
26 |
124 |
780 |
| Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs |
1 |
1 |
6 |
148 |
8 |
18 |
64 |
1,520 |
| Market Conditions and Retirement of Physical Capital: Evidence fron Oil Tankers |
0 |
0 |
3 |
34 |
0 |
0 |
10 |
397 |
| Measuring competence?: exploring firm effects in pharmaceutical research |
6 |
10 |
62 |
347 |
11 |
32 |
145 |
692 |
| Not Invented Here? Innovation in Company Towns |
0 |
0 |
0 |
0 |
5 |
5 |
5 |
5 |
| Patent Thickets, Licensing and Innovative Performance |
1 |
3 |
42 |
42 |
5 |
10 |
44 |
44 |
| Patents and the Survival of Internet-related IPOs |
2 |
6 |
14 |
53 |
6 |
13 |
30 |
134 |
| Patents, Thickets, and the Financing of Early-Stage Firms: Evidence from the Software Industry |
0 |
0 |
8 |
61 |
6 |
8 |
28 |
99 |
| Public & Private Spillovers, Location and the Productivity of Pharmaceutical Research |
1 |
5 |
15 |
82 |
3 |
10 |
35 |
183 |
| Public-Private Interaction and the Productivity of Pharmaceutical Research |
0 |
2 |
23 |
136 |
8 |
30 |
80 |
533 |
| Racing or spilling?: the determinants of research productivity in ethical drug discovery |
0 |
1 |
5 |
38 |
5 |
7 |
19 |
107 |
| Racing to invest?: the dynamics of competition in ethical drug discovery |
5 |
8 |
24 |
183 |
8 |
14 |
47 |
336 |
| Scale, Scope and Spillovers: The Determinants of Research Productivity in Drug Discovery |
0 |
0 |
0 |
1 |
3 |
9 |
32 |
310 |
| Scale, Scope and Spillovers: The Determinants of Research Productivity in the Pharmaceutical Industry |
3 |
7 |
35 |
267 |
12 |
27 |
99 |
576 |
| Scale, scope and spillovers: the determinants of research productivity in ethical drug discovery |
0 |
2 |
8 |
116 |
1 |
3 |
21 |
201 |
| The Diffusion of Science-Driven Drug Discovery: Organizational Change in Pharmaceutical Research |
3 |
5 |
19 |
271 |
19 |
47 |
158 |
1,597 |
| University Research, Industrial R&D, and the Anchor Tenant Hypothesis |
2 |
9 |
21 |
167 |
8 |
19 |
70 |
576 |
| Total Working Papers |
40 |
110 |
513 |
4,157 |
206 |
538 |
2,057 |
18,037 |
| Journal Article |
File Downloads |
Abstract Views |
| Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
| Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery |
2 |
6 |
28 |
175 |
45 |
60 |
134 |
660 |
| Analysis of Patent Data--A Mixed-Poisson-Regression-Model Approach |
0 |
0 |
0 |
0 |
11 |
28 |
106 |
662 |
| Characteristics of Demand for Pharmaceutical Products: An Examination of Four Cephalosporins |
3 |
7 |
47 |
298 |
7 |
18 |
101 |
844 |
| Faster, smaller, cheaper: an hedonic price analysis of PDAs |
0 |
1 |
4 |
4 |
0 |
2 |
23 |
23 |
| Generics and New Goods in Pharmaceutical Price Indexes |
3 |
4 |
11 |
156 |
4 |
12 |
38 |
625 |
| Generics and New Goods in Pharmaceutical Price Indexes: Reply |
0 |
0 |
0 |
25 |
1 |
2 |
7 |
121 |
| Industry Effects and Appropriability Measures in the Stock Market's Valuation of R&D and Patents |
0 |
2 |
16 |
155 |
1 |
7 |
49 |
504 |
| Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs |
0 |
1 |
3 |
13 |
0 |
6 |
45 |
166 |
| New Pills for Poor People? Empirical Evidence after GATT |
3 |
5 |
28 |
130 |
6 |
8 |
54 |
257 |
| Opportunity costs and entrepreneurial activity |
3 |
6 |
30 |
58 |
6 |
11 |
44 |
107 |
| Racing to Invest? The Dynamics of Competition in Ethical Drug Discovery |
0 |
0 |
0 |
0 |
5 |
6 |
38 |
458 |
| Scale and scope in drug development: unpacking the advantages of size in pharmaceutical research |
0 |
3 |
22 |
115 |
5 |
10 |
50 |
268 |
| Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery |
5 |
11 |
43 |
333 |
10 |
25 |
86 |
948 |
| The anchor tenant hypothesis: exploring the role of large, local, R&D-intensive firms in regional innovation systems |
0 |
4 |
10 |
76 |
1 |
8 |
33 |
265 |
| Total Journal Articles |
19 |
50 |
242 |
1,538 |
102 |
203 |
808 |
5,908 |
|
|
LogEc is hosted by the
Swedish Business School at Örebro University.